BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patoulias D, Katsimardou A, Fragakis N, Papadopoulos C, Doumas M. Effect of SGLT-2 inhibitors on cardiac autonomic function in type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Acta Diabetol 2023;60:1-8. [PMID: 35986116 DOI: 10.1007/s00592-022-01958-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Theofilis P, Oikonomou E, Tsioufis K, Tousoulis D. Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors. Life (Basel) 2023;13. [PMID: 36836854 DOI: 10.3390/life13020497] [Reference Citation Analysis]
2 Patoulias D, Fragakis N, Rizzo M. The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest. Life (Basel) 2022;12. [PMID: 36556427 DOI: 10.3390/life12122062] [Reference Citation Analysis]
3 Scheen AJ. Dissecting the reduction in cardiovascular death with SGLT2 inhibitors: Potential contribution of effects on ventricular arrhythmias and sudden cardiac death? Diabetes Epidemiology and Management 2022;8:100107. [DOI: 10.1016/j.deman.2022.100107] [Reference Citation Analysis]